Lauren T. Fleming
Overview
Lauren Fleming is an associate in Crowell & Moring’s Washington, D.C. office and is a member of the firm’s Antitrust & Competition Group. Lauren has a wide variety of experience in antitrust issues, including merger reviews, government investigations, and class action litigation. She counsels and represents clients before the U.S. Department of Justice and Federal Trade Commission.
Career & Education
- University of Kansas, B.A., Magna cum Laude, 2016
- University of Minnesota Law School, J.D., cum Laude, 2019
- District of Columbia
- Kansas (inactive)
- Missouri (Inactive)
Lauren 's Insights
Client Alert | 8 min read | 01.11.24
The saga of DNA-sequencing firm Illumina’s quest to acquire cancer detection-test maker Grail ended last month when the Fifth Circuit largely upheld the Federal Trade Commission’s decision to block the deal. The appellate decision is significant on several levels. First, it is the first time in decades that either federal antitrust enforcer has succeeded in blocking or forcing the abandonment of a vertical merger after litigating to a decision.
Client Alert | 4 min read | 01.06.23
FTC Cracks Down on Non-Competes as Unfair Methods of Competition
Client Alert | 8 min read | 11.15.22
FTC Issues New Policy Statement on “Rigorous Enforcement” Against Unfair Methods of Competition
Client Alert | 5 min read | 11.08.22
Supreme Court Hears Argument Regarding Challenges to Administrative Agency Procedures
Representative Matters
- Represented a retailer in obtaining regulatory clearance of a merger after receiving a Second Request.
- Represented a defendant in a lawsuit filed by the Department of Justice to block a proposed merger.
- Represented a defendant in a collection of class action and individual antitrust lawsuits alleging that chicken producers conspired to reduce the supply of chicken in an effort to drive up prices.
- Represented a defendant in a collection of class action and individual antitrust lawsuits alleging production-fixing claims against pork producers.
Lauren 's Insights
Client Alert | 8 min read | 01.11.24
The saga of DNA-sequencing firm Illumina’s quest to acquire cancer detection-test maker Grail ended last month when the Fifth Circuit largely upheld the Federal Trade Commission’s decision to block the deal. The appellate decision is significant on several levels. First, it is the first time in decades that either federal antitrust enforcer has succeeded in blocking or forcing the abandonment of a vertical merger after litigating to a decision.
Client Alert | 4 min read | 01.06.23
FTC Cracks Down on Non-Competes as Unfair Methods of Competition
Client Alert | 8 min read | 11.15.22
FTC Issues New Policy Statement on “Rigorous Enforcement” Against Unfair Methods of Competition
Client Alert | 5 min read | 11.08.22
Supreme Court Hears Argument Regarding Challenges to Administrative Agency Procedures
Lauren 's Insights
Client Alert | 8 min read | 01.11.24
The saga of DNA-sequencing firm Illumina’s quest to acquire cancer detection-test maker Grail ended last month when the Fifth Circuit largely upheld the Federal Trade Commission’s decision to block the deal. The appellate decision is significant on several levels. First, it is the first time in decades that either federal antitrust enforcer has succeeded in blocking or forcing the abandonment of a vertical merger after litigating to a decision.
Client Alert | 4 min read | 01.06.23
FTC Cracks Down on Non-Competes as Unfair Methods of Competition
Client Alert | 8 min read | 11.15.22
FTC Issues New Policy Statement on “Rigorous Enforcement” Against Unfair Methods of Competition
Client Alert | 5 min read | 11.08.22
Supreme Court Hears Argument Regarding Challenges to Administrative Agency Procedures
